Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Oct 1;129(10):4032-4040.
doi: 10.1172/JCI129192.

Deciphering the cellular interplays underlying obesity-induced adipose tissue fibrosis

Affiliations
Review

Deciphering the cellular interplays underlying obesity-induced adipose tissue fibrosis

Geneviève Marcelin et al. J Clin Invest. .

Abstract

Obesity originates from an imbalance between caloric intake and energy expenditure that promotes adipose tissue expansion, which is necessary to buffer nutrient excess. Patients with higher visceral fat mass are at a higher risk of developing severe complications such as type 2 diabetes and cardiovascular and liver diseases. However, increased fat mass does not fully explain obesity's propensity to promote metabolic diseases. With chronic obesity, adipose tissue undergoes major remodeling, which can ultimately result in unresolved chronic inflammation leading to fibrosis accumulation. These features drive local tissue damage and initiate and/or maintain multiorgan dysfunction. Here, we review the current understanding of adipose tissue remodeling with a focus on obesity-induced adipose tissue fibrosis and its relevance to clinical manifestations.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors have declared that no conflict of interest exists.

Figures

Figure 1
Figure 1. Heterogeneity among progenitors in the adipose tissue.
Adipose tissue progenitors (or precursors), often located in the vicinity of the vascular network, constitute a heterogeneous population. They can be discriminated through their capacity to differentiate into mature adipocytes and also by their level of commitment into the adipocyte differentiation program. The application of flow cytometry using various markers as well as single-cell RNA sequencing has enabled the identification of multiple cell populations. The CD9hi progenitors exhibited very limited adipogenic capacity with a high propensity for the production of extracellular matrix components. CD9hi progenitors include mesothelial cells, whose contribution in adipose tissue remodeling is currently unresolved. Further investigations are still needed to establish the relationship between these various populations of progenitors. In addition, a better understanding of the critical functional determinants and whether acquired phenotypes are reversible is needed.
Figure 2
Figure 2. Illustration of adipose tissue fibrosis in obese subjects.
Obesity increases collagen deposition and myofibrocyte distribution in adipose tissue. (A) A section of adipose tissue with no fibrosis. (B) In contrast, fibrotic adipose tissue contains fibrosis-forming collagen bundles that trap adipocytes. Fibrosis can also be observed around a blood vessel (lower left) and around a crown-like structure with macrophages and inflammatory cells.
Figure 3
Figure 3. Adipose tissue fibrosis in obese subjects.
With chronic obesity, WAT depots undergo continual remodeling, becoming pathological. Combined with unadapted vascularization promoting hypoxia and unresolved inflammation, alteration of the equilibrium between the myofibroblast and the adipogenic fate of adipose progenitors is important in the unhealthy growth of adipose tissue. Various signals and transcription factors were found to be important in controlling the fate of progenitors.

References

    1. Marcelin G, Chua S. Contributions of adipocyte lipid metabolism to body fat content and implications for the treatment of obesity. Curr Opin Pharmacol. 2010;10(5):588–593. doi: 10.1016/j.coph.2010.05.008. - DOI - PMC - PubMed
    1. Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev. 1994;74(4):761–811. doi: 10.1152/physrev.1994.74.4.761. - DOI - PubMed
    1. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev. 2000;21(6):697–738. doi: 10.1210/edrv.21.6.0415. - DOI - PubMed
    1. Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev. 2010;11(1):11–18. doi: 10.1111/j.1467-789X.2009.00623.x. - DOI - PubMed
    1. Schoettl T, Fischer IP, Ussar S. Heterogeneity of adipose tissue in development and metabolic function. J Exp Biol. 2018;221(pt suppl 1):jeb162958. - PubMed

Publication types